Executive Director's Letters

Executive Director's Letters

Welcome To The Blog!

I will never forget my experience with LCH, as I am sure is true for so many histiocytosis patients, families, and friends. I can still remember what it felt like to hear a diagnosis of a rare disease, the visits to the hospital, the pain, the uncertainty, the heroes on my medical team – it is all vivid as though it were only a week ago. One of the most important pieces of recovery for me, was the opportunity to connect with other families and patients; to hear their stories and learn from their experience. The world of rare disease can feel lonely, and it is often hard to talk about what we have seen, felt, and been through. Even if we meet someone who has suffered from a rare or debilitating condition, their journey may have been very different from our own. Years ago, we did not have the technology we do today to email one another or to connect on social media. We connected through a PenPal club, finding comfort in the words of others, pressed into the lined paper or edges of notebooks and sent via mail to the eager eyes of a fellow Histio Warrior or family member. I still have so many letters from the PenPal club. They are tucked away in a special box in my house and are a memory I treasure. I admit, I revisit those words and stories often.  

Now, everything has become digital. And the benefit of that is the far-reaching edges of the world that we can all now touch. So, this blog, along with the Beyond the Diagnosis Podcast, our regional/local meetings, and any community engagements we can facilitate, are our way of connecting with you. I invite you to come along with the Association Team as we share our work, share stories of warriors and families, and bring you deeper into the impact you all have on us. I encourage you to comment, share, and to bring new ideas forward to me; know that while these are just my thoughts down on paper, they are meant for each one of you, to be a source of connection and to talk about the topics most important to you.  

I look forward to these posts and look forward to hearing what you would like to hear!


Email: deannafournier@histio.org
Phone: (856) 589-6606
Click Here for Other Ways to Connect

Patient Centered – Rare Disease Led

May 9, 2024 Comments Off on Patient Centered – Rare Disease Led

The Patient Centered Outcomes Research Institute (PCORI)’s federally mandated Rare Disease Advisory Panel (RDAP) has been an incredible opportunity. For the last three (3) years I have served on the…

Read More

Pediatric to Adult: Our Focus on Transitions

March 21, 2024 Comments Off on Pediatric to Adult: Our Focus on Transitions
mountain view

15 years ago, investigators around the world were still searching for effective therapies for histiocytic disorders. We were beginning to learn about the genetic mutations that are present with histio.…

Read More

Rareness Creating Awareness – Rare Disease Day 2024 Recap

March 7, 2024 Comments Off on Rareness Creating Awareness – Rare Disease Day 2024 Recap

This Rare Disease Day was the rarest of all. It was on one that fell on a Leap Day. Given this occasion, we went all out for Rare Disease Day…

Read More

Setting A Course for the Future – The Histiocytic Disorders Workshop

February 22, 2024 Comments Off on Setting A Course for the Future – The Histiocytic Disorders Workshop

On February 1st and 2nd of this year, approximately 70 healthcare providers and patient advocates came together at St. Jude Children’s Hospital to brainstorm solutions to gaps and challenges for…

Read More

2023 Histiocytosis Association Research Grant Recipients

February 8, 2024 Comments Off on 2023 Histiocytosis Association Research Grant Recipients
2023 Histiocytosis Association Research Grant Recipients Featured Photo. From left to right. Polina Shindiapina, Randy Cron, Ruthy Shiloh & Sarah Elitzur, and Nicole Coufal

Since 1992, because of your generosity and dedication, the Histiocytosis Association has granted over $7.5 million for research projects in 14 countries – that’s 211 projects, 7 clinical trials and…

Read More